Salvianolic acid A inhibits calpain activation and eNOS uncoupling during focal cerebral ischemia in mice

Phytomedicine. 2017 Feb 15:25:8-14. doi: 10.1016/j.phymed.2016.12.004. Epub 2016 Dec 12.

Abstract

Background: Salvianolic acid A (SAA) is obtained from Chinese herb Salviae Miltiorrhizae Bunge (Labiatae), has been reported to have the protective effects against cardiovascular and neurovascular diseases.

Hypothesis: The aim of present study was to investigate the relationship between the effectiveness of SAA against neurovascular injury and its effects on calpain activation and endothelial nitric oxide synthase (eNOS) uncoupling.

Study design: SAA or vehicle was given to C57BL/6 male mice for seven days before the occlusion of middle cerebral artery (MCAO) for 60min.

Methods: High-resolution positron emission tomography scanner (micro-PET) was used for small animal imaging to examine glucose metabolism. Rota-rod time and neurological deficit scores were calculated after 24h of reperfusion. The volume of infarction was determined by Nissl-staining. The calpain proteolytic activity and eNOS uncoupling were determined by western blot analysis.

Results: SAA administration increased glucose metabolism and ameliorated neuronal damage after brain ischemia, paralleled with decreased neurological deficit and volume of infarction. In addition, SAA pretreatment inhibited eNOS uncoupling and calpain proteolytic activity. Furthermore, SAA inhibited peroxynitrite (ONOO-) generation and upregulates AKT, FKHR and ERK phosphorylation.

Conclusion: These findings strongly suggest that SAA elicits a neurovascular protective role through the inhibition of eNOS uncoupling and ONOO- formation. Moreover, SAA attenuates spectrin and calcineurin breakdown and therefore protects the brain against ischemic/reperfusion injury.

Keywords: Neurovascular protection; Oxidative stress; Salvianolic acid A; Stroke; eNOS uncoupling.

MeSH terms

  • Animals
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Brain Ischemia / drug therapy
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • Caffeic Acids / pharmacology*
  • Caffeic Acids / therapeutic use
  • Calpain / metabolism*
  • Drugs, Chinese Herbal / pharmacology*
  • Drugs, Chinese Herbal / therapeutic use
  • Infarction, Middle Cerebral Artery / prevention & control
  • Lactates / pharmacology*
  • Lactates / therapeutic use
  • Male
  • Mice, Inbred C57BL
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use
  • Nitric Oxide Synthase Type III / metabolism*
  • Phosphorylation
  • Phytotherapy
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Salvia miltiorrhiza / chemistry*
  • Up-Regulation

Substances

  • Caffeic Acids
  • Drugs, Chinese Herbal
  • Lactates
  • Neuroprotective Agents
  • salvianolic acid A
  • Nitric Oxide Synthase Type III
  • Calpain